Palo Alto, CA, United States of America

Xiao Dong Yang



 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 317(Granted Patents)


Location History:

  • Glendale, CA (US) (2003)
  • Palo Alto, CA (US) (2003 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Trailblazing Work of Inventor Xiao Dong Yang

Introduction: Meet Xiao Dong Yang, a prolific inventor based in Palo Alto, CA, who has made significant contributions to the field with his innovative patents and groundbreaking research.

Latest Patents: With an impressive portfolio of 11 patents, Xiao Dong Yang's latest invention focuses on antibodies directed to the deletion mutants of the epidermal growth factor receptor, particularly the type III deletion mutant, EGFRvIII. These antibodies have far-reaching implications in diagnostic and therapeutic formulations, offering novel approaches in the fight against certain cancers.

Career Highlights: Xiao Dong Yang has lent his expertise to renowned companies such as Amgen Fremont Inc. and Pixim, Incorporated, where he has spearheaded research and development initiatives that have pushed the boundaries of scientific innovation. His work has not only garnered recognition but has also inspired others in the industry.

Collaborations: Throughout his career, Xiao Dong Yang has collaborated with esteemed professionals such as Richard F. Weber and Xiao Feng, further enriching his research endeavors and fostering a culture of collaboration within the scientific community. These partnerships have led to synergies that have propelled his inventions to new heights.

Conclusion: In conclusion, Xiao Dong Yang stands as a testament to the power of innovation and collaboration in driving progress within the field of biotechnology. His relentless pursuit of scientific excellence and commitment to advancing medical research make him a true trailblazer in the realm of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…